NCT01930786已完成不适用
ASPIRE: Adult SPasticity International REgistry on BOTOX® Treatment
适应症
干预措施
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- Allergan
- 入组人数
- 744
- 试验地点
- 55
- 主要终点
- Percentage of Patients Reporting Satisfaction with Treatment
研究概览
简要总结
This is a registry study in adults with spasticity to determine onabotulinumtoxinA use in clinical practice. Treatment will be administered in accordance with physician standard practice. All treatment decisions lie with the physician.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Only
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Treatment with onabotulinumtoxinA according to the decision of the physician for spasticity
- •Willingness to complete study questionnaires and answer study questions by phone or internet
排除标准
- •Concurrent participation in a clinical trial for spasticity
研究组 & 干预措施
onabotulinumtoxinA
onabotulinumtoxinA administered according to physician standard of care. All treatment decisions lie with the physician.
干预措施: onabotulinumtoxinA (Drug)
结局指标
主要结局
Percentage of Patients Reporting Satisfaction with Treatment
时间窗: 5 Weeks
Percentage of Health Care Providers Reporting Satisfaction with Treatment
时间窗: 12 Weeks
次要结局
- Disability Assessment on a 4-Point Scale(12 Weeks)
- Severity of Pain on an 11-Point Scale(5 Weeks)
- Physical Functioning on a 5-Point Scale(5 Weeks)
研究者
研究点 (55)
Loading locations...
相似试验
已完成
3 期
Integrated Management Enhances Functional Gains in Children With Cerebral Palsy Treated by BoNT-ACerebral PalsyNCT03302871Kocaeli University40
撤回
不适用
Spasticity Registry Evaluating Epidemiology, Treatment Patterns and Clinical NeedsMuscle SpasticityNCT02145650Allergan
终止
3 期
OnabotulinumtoxinA Treatment in Adult Patients With Upper Limb SpasticityMuscle SpasticityStrokeNCT02145676Allergan53
已完成
不适用
A Study to Collect Participants Experience of Living With Adult Upper Limb (AUL) Spasticity and to Assess the Arm Activity Measure (ArmA)Spastic HemiparesisMuscle SpasticityNCT05546190Ipsen25
已完成
3 期
Botulinum Toxin in Patients With Spastic Lower Limb Paresis Associated With Multiple SclerosisMultiple SclerosisNCT04595045Aránzazu Vázquez Doce84